Literature DB >> 20636645

Similar immune profile in bipolar disorder and schizophrenia: selective increase in soluble tumor necrosis factor receptor I and von Willebrand factor.

Elisa Brietzke, Antônio Lúcio Teixeira.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20636645     DOI: 10.1111/j.1399-5618.2010.00822.x

Source DB:  PubMed          Journal:  Bipolar Disord        ISSN: 1398-5647            Impact factor:   6.744


× No keyword cloud information.
  6 in total

1.  A meta-analysis of blood cytokine network alterations in psychiatric patients: comparisons between schizophrenia, bipolar disorder and depression.

Authors:  D R Goldsmith; M H Rapaport; B J Miller
Journal:  Mol Psychiatry       Date:  2016-02-23       Impact factor: 15.992

2.  Proinflammatory Cytokines, Mood, and Sleep in Interepisode Bipolar Disorder and Insomnia: A Pilot Study With Implications for Psychosocial Interventions.

Authors:  Michael R Dolsen; Adriane M Soehner; Allison G Harvey
Journal:  Psychosom Med       Date:  2018-01       Impact factor: 4.312

3.  Changes in inflammation with treatment for bipolar II depression: Pilot trial data on differential effects of psychotherapy and medication.

Authors:  Jess G Fiedorowicz; Jill M Cyranowski; Zhuangzhuang Liu; Holly A Swartz
Journal:  Neurol Psychiatry Brain Res       Date:  2019-08-10

Review 4.  The Potential Role of the NLRP3 Inflammasome as a Link between Mitochondrial Complex I Dysfunction and Inflammation in Bipolar Disorder.

Authors:  Helena Kyunghee Kim; Wenjun Chen; Ana Cristina Andreazza
Journal:  Neural Plast       Date:  2015-05-13       Impact factor: 3.599

5.  CD4⁺ but not CD8⁺ T cells revert the impaired emotional behavior of immunocompromised RAG-1-deficient mice.

Authors:  L Rattazzi; G Piras; M Ono; R Deacon; C M Pariante; F D'Acquisto
Journal:  Transl Psychiatry       Date:  2013-07-09       Impact factor: 6.222

Review 6.  Endothelial dysfunction in neuroprogressive disorders-causes and suggested treatments.

Authors:  Gerwyn Morris; Basant K Puri; Lisa Olive; Andre Carvalho; Michael Berk; Ken Walder; Lise Tuset Gustad; Michael Maes
Journal:  BMC Med       Date:  2020-10-19       Impact factor: 8.775

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.